New drug D-2570 aims to quiet Flare-Ups in ulcerative colitis
NCT ID NCT07035041
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study tests whether an experimental drug called D-2570 can help people with moderately to severely active ulcerative colitis achieve remission. About 120 adults will receive either D-2570 or a placebo daily for 12 weeks. The main goal is to see if more people on D-2570 reach clinical remission, meaning less frequent stools, no rectal bleeding, and improved endoscopic findings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental drug called D-2570
- What this could lead to
- If successful, D-2570 could offer a new treatment option for people with moderate to severe ulcerative colitis, potentially helping them achieve remission without the need for lifelong therapy.
- What could go wrong
- This is an early Phase 2 trial with only 120 participants, so results may not apply to everyone. The drug may not work better than placebo, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310016, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut check: 4,000-Person study links diet, genes, and stomach troubles
- New drug LYNC-101 enters first human trials for ulcerative colitis
- New oral drug could replace steroids for severe colitis Flare-Ups
- New hope for ulcerative colitis: experimental drug OD-07656 enters Mid-Stage trial
- Healthy stool study aims to sharpen IBD diagnosis
- Rethinking routine drugs: could skipping allergy meds before IBD infusions be better?